Aurore Michelin, Author at Labiotech.eu

Produced by Inpart

13 Jun 2025

R&D trends and breakthrough innovations: Chemical & material sustainability

This report identifies the latest trends in sustainable materials and green chemistry R&D, providing scientific decision-makers with a roadmap of high-impact opportunities, emerging technologies, and potential future partners.

June 13, 2025

Produced by Inpart

Reports

Produced by Inpart

19 May 2025

Oncology R&D trends and breakthrough innovations

Explore the latest in oncology R&D with Inpart’s new trends report, featuring emerging technologies, breakthrough innovations, and expert insights shaping the future of cancer research.

May 19, 2025

Produced by Inpart

Webinars 5 May 2025

AI in antibody discovery: From in silico analysis to AI-enabled data management

Explore how AI and bioinformatics are reshaping antibody discovery, from in silico design to efficient data management.

May 5, 2025

Whitepapers 28 Apr 2025

Function-focused single-cell analysis to accelerate antibody discovery

Discover how early functional screening at the single-cell level transforms therapeutic development of your antibodies.

April 28, 2025

Reports

Produced by Inpart

3 Mar 2025

R&D trends: Biotech assets & discovery platforms

Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D.

March 3, 2025

Produced by Inpart

Reports

Produced by Inpart

7 Feb 2025

Partnering 2030: FME Industries Report

Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships.

February 7, 2025

Produced by Inpart

Reports

Produced by Inpart

7 Jan 2025

Partnering 2030: Biopharma Report

Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms.

January 7, 2025

Produced by Inpart

Reports

Produced by Inpart

11 Dec 2024

Antibody Therapy R&D trends and breakthrough innovations

Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart.

December 11, 2024

Produced by Inpart

Reports 25 Sep 2024

Current trends & innovations in 3D organoids

Discover how 3D organoids are already shaping research & drug development today and explore their future potential.

September 25, 2024

Podcast 16 Aug 2024

Challenging the European biotech funding status quo

Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin.

August 16, 2024

Podcast 9 Aug 2024

Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA

This week, we discuss epigenetic editing, why it’s reversible, treating FSHD and other conditions, with Epic Bio founder, Dr Stanley Qi.

August 9, 2024

Podcast 2 Aug 2024

Rebroadcast: How does AI assist drug discovery?

Listen to our podcast to discover how AI is revolutionizing drug discovery by tackling “undruggable” targets like KRAS.

August 2, 2024

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Aurore Michelin

Articles by Aurore Michelin

R&D trends and breakthrough innovations: Chemical & material sustainability

Oncology R&D trends and breakthrough innovations

AI in antibody discovery: From in silico analysis to AI-enabled data management

Function-focused single-cell analysis to accelerate antibody discovery

R&D trends: Biotech assets & discovery platforms

Partnering 2030: FME Industries Report

Partnering 2030: Biopharma Report

Antibody Therapy R&D trends and breakthrough innovations

Current trends & innovations in 3D organoids

Challenging the European biotech funding status quo

Rebroadcast: Epigenetic editing – the power of CRISPR without cutting DNA

Rebroadcast: How does AI assist drug discovery?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Articles by Aurore Michelin

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!